Perception of COVID-19 Vaccination Amongst Physicians in Colombia

Letter Infectious Diseases

Willingness to vaccinate against COVID-19 in Australia

Rachael H. Dodd et al.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Letter Virology

High impact of SARS-CoV-2 or COVID-19 in the Honduran health personnel

Karla Iveth Henriquez-Marquez et al.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Editorial Material Infectious Diseases

COVID-19 vaccines under the International Health Regulations - We must use the WHO International Certificate of Vaccination or Prophylaxis

Eskild Petersen et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera

Xuping Xie et al.

Summary: The study found that human sera from recipients of the BNT162b2 vaccine can neutralize SARS-CoV-2 viruses containing key spike mutations from the newly emerged UK and SA variants.

NATURE MEDICINE (2021)

Add to Collection

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Variants, vaccines and vaccination passports: Challenges and chances for travel medicine in 2021

Patricia Schlagenhauf et al.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)

Add to Collection

News Item Medicine, General & Internal

Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

News Item Medicine, General & Internal

Covid-19: South Africa pauses use of Oxford vaccine after study casts doubt on efficacy against variant

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Immunology

Acceptability of COVID-19 Vaccination among Greek Health Professionals

Dimitrios Papagiannis et al.

Summary: The study found a high acceptance rate of COVID-19 vaccines among physicians, dentists, and pharmacists, with age over 45, absence of fear over vaccine safety, and information from Greek public health authorities being significant factors associated with vaccine acceptance.

VACCINES (2021)

Add to Collection

Article Immunology

Spain's Hesitation at the Gates of a COVID-19 Vaccine

Hans Eguia et al.

Summary: The study found that in Spain, approximately 22.43% of respondents stated they would not be vaccinated, with non-health workers or unemployed individuals, physicians, other health workers, and nurses being the main groups. Concerns about the effectiveness of the vaccination, lack of safety when vaccinating, and potential dangerous adverse effects were the main reasons provided.

VACCINES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Willingness of Greek general population to get a COVID-19 vaccine

Georgia Kourlaba et al.

Summary: The study examined the willingness of adult residents in Greece to receive a COVID-19 vaccine, with only 57.7% of respondents stating they would get vaccinated. Factors such as age, vulnerability to the virus, beliefs about its origins, perceptions of its severity compared to other viruses, and knowledge score on COVID-19 were significantly associated with willingness to get vaccinated.

GLOBAL HEALTH RESEARCH AND POLICY (2021)

Add to Collection

Review Virology